Conversion to Wet AMD after Izervay35 x angesehen83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15. März 2026
Conversion to Wet AMD after Izervay39 x angesehen83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15. März 2026
Conversion to Wet AMD after Izervay31 x angesehen83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15. März 2026
Conversion to Wet AMD after Izervay47 x angesehen83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15. März 2026
Conversion to Wet AMD after Izervay36 x angesehen83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15. März 2026
Conversion to Wet AMD after Izervay29 x angesehen83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15. März 2026
Conversion to Wet AMD after Izervay40 x angesehen83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15. März 2026
Conversion to Wet AMD after Izervay34 x angesehen83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15. März 2026
Conversion to Wet AMD after Izervay40 x angesehen83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15. März 2026
Conversion to Wet AMD after Izervay32 x angesehen83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15. März 2026
Conversion to Wet AMD after Izervay34 x angesehen83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15. März 2026
Conversion to Wet AMD after Izervay28 x angesehen83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15. März 2026
Conversion to Wet AMD after Izervay40 x angesehen83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15. März 2026
Conversion to Wet AMD after Izervay35 x angesehen83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15. März 2026
Conversion to Wet AMD after Izervay29 x angesehen83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15. März 2026
Conversion to Wet AMD after Izervay34 x angesehen83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15. März 2026
Conversion to Wet AMD after Izervay32 x angesehen83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15. März 2026
Peripapillary CNVM No Treatment59 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment32 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment42 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment40 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment28 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment31 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment42 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment42 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment34 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment34 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment30 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment24 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment35 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment27 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment29 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment38 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment31 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment32 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment39 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment44 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment34 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment36 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment36 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment40 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment40 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment24 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment40 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment37 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Peripapillary CNVM No Treatment33 x angesehen85 year old with peripapillary CNVM watched for many years.18. Februar 2026
Post Anti-VEGF RPE Tear (Vabysmo)42 x angesehen87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011. Januar 2026
Post Anti-VEGF RPE Tear (Vabysmo)51 x angesehen87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011. Januar 2026
Post Anti-VEGF RPE Tear (Vabysmo)41 x angesehen87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011. Januar 2026
Post Anti-VEGF RPE Tear (Vabysmo)58 x angesehen87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011. Januar 2026
Post Anti-VEGF RPE Tear (Vabysmo)44 x angesehen87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011. Januar 2026
Post Anti-VEGF RPE Tear (Vabysmo)52 x angesehen87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011. Januar 2026
Post Anti-VEGF RPE Tear (Vabysmo)46 x angesehen87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011. Januar 2026
Post Anti-VEGF RPE Tear (Vabysmo)48 x angesehen87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011. Januar 2026
Post Anti-VEGF RPE Tear (Vabysmo)41 x angesehen87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011. Januar 2026
Post Anti-VEGF RPE Tear (Vabysmo)40 x angesehen87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011. Januar 2026
Post Anti-VEGF RPE Tear (Vabysmo)52 x angesehen87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011. Januar 2026
Post Anti-VEGF RPE Tear (Vabysmo)44 x angesehen87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011. Januar 2026
Post Anti-VEGF RPE Tear (Vabysmo)55 x angesehen87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011. Januar 2026
Post Anti-VEGF RPE Tear (Vabysmo)46 x angesehen87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011. Januar 2026
Post Anti-VEGF RPE Tear (Vabysmo)43 x angesehen87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011. Januar 2026
Post Anti-VEGF RPE Tear (Vabysmo)52 x angesehen87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011. Januar 2026
Post Anti-VEGF RPE Tear (Vabysmo)46 x angesehen87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011. Januar 2026
Post Anti-VEGF RPE Tear (Vabysmo)56 x angesehen87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011. Januar 2026
Idiopathic Polypoidal Choroidal Vasculopathy160 x angesehen83 year old man with wet AMD for 12 years resistant to Anti-VEGF therapy but responsive to PDT12. Februar 2025
Idiopathic Polypoidal Choroidal Vasculopathy148 x angesehen83 year old man with wet AMD for 12 years resistant to Anti-VEGF therapy but responsive to PDT12. Februar 2025
Idiopathic Polypoidal Choroidal Vasculopathy138 x angesehen83 year old man with wet AMD for 12 years resistant to Anti-VEGF therapy but responsive to PDT12. Februar 2025
Idiopathic Polypoidal Choroidal Vasculopathy141 x angesehen83 year old man with wet AMD for 12 years resistant to Anti-VEGF therapy but responsive to PDT12. Februar 2025
Idiopathic Polypoidal Choroidal Vasculopathy128 x angesehen83 year old man with wet AMD for 12 years resistant to Anti-VEGF therapy but responsive to PDT12. Februar 2025
Idiopathic Polypoidal Choroidal Vasculopathy146 x angesehen83 year old man with wet AMD for 12 years resistant to Anti-VEGF therapy but responsive to PDT12. Februar 2025
Idiopathic Polypoidal Choroidal Vasculopathy151 x angesehen83 year old man with wet AMD for 12 years resistant to Anti-VEGF therapy but responsive to PDT12. Februar 2025
Idiopathic Polypoidal Choroidal Vasculopathy134 x angesehen83 year old man with wet AMD for 12 years resistant to Anti-VEGF therapy but responsive to PDT12. Februar 2025
Idiopathic Polypoidal Choroidal Vasculopathy124 x angesehen83 year old man with wet AMD for 12 years resistant to Anti-VEGF therapy but responsive to PDT12. Februar 2025
Idiopathic Polypoidal Choroidal Vasculopathy155 x angesehen83 year old man with wet AMD for 12 years resistant to Anti-VEGF therapy but responsive to PDT12. Februar 2025
Idiopathic Polypoidal Choroidal Vasculopathy132 x angesehen83 year old man with wet AMD for 12 years resistant to Anti-VEGF therapy but responsive to PDT12. Februar 2025
Idiopathic Polypoidal Choroidal Vasculopathy133 x angesehen83 year old man with wet AMD for 12 years resistant to Anti-VEGF therapy but responsive to PDT12. Februar 2025
Idiopathic Polypoidal Choroidal Vasculopathy103 x angesehen83 year old man with wet AMD for 12 years resistant to Anti-VEGF therapy but responsive to PDT12. Februar 2025
Idiopathic Polypoidal Choroidal Vasculopathy100 x angesehen83 year old man with wet AMD for 12 years resistant to Anti-VEGF therapy but responsive to PDT12. Februar 2025
Idiopathic Polypoidal Choroidal Vasculopathy83 x angesehen83 year old man with wet AMD for 12 years resistant to Anti-VEGF therapy but responsive to PDT12. Februar 2025
Idiopathic Polypoidal Choroidal Vasculopathy93 x angesehen83 year old man with wet AMD for 12 years resistant to Anti-VEGF therapy but responsive to PDT12. Februar 2025
Idiopathic Polypoidal Choroidal Vasculopathy83 x angesehen83 year old man with wet AMD for 12 years resistant to Anti-VEGF therapy but responsive to PDT12. Februar 2025
Idiopathic Polypoidal Choroidal Vasculopathy76 x angesehen83 year old man with wet AMD for 12 years resistant to Anti-VEGF therapy but responsive to PDT12. Februar 2025
Idiopathic Polypoidal Choroidal Vasculopathy108 x angesehen83 year old man with wet AMD for 12 years resistant to Anti-VEGF therapy but responsive to PDT12. Februar 2025
Wet AMD - Occult CNVM and Geographic atrophy99 x angesehen77 year old female with mild vision loss - 20/32 - responded to Avastin19. Dezember 2024
Wet AMD - Occult CNVM and Geographic atrophy105 x angesehen77 year old female with mild vision loss - 20/32 - responded to Avastin19. Dezember 2024
Wet AMD - Occult CNVM and Geographic atrophy82 x angesehen77 year old female with mild vision loss - 20/32 - responded to Avastin19. Dezember 2024
Wet AMD - Occult CNVM and Geographic atrophy91 x angesehen77 year old female with mild vision loss - 20/32 - responded to Avastin19. Dezember 2024
Wet AMD - Occult CNVM and Geographic atrophy90 x angesehen77 year old female with mild vision loss - 20/32 - responded to Avastin19. Dezember 2024
Wet AMD - Occult CNVM and Geographic atrophy82 x angesehen77 year old female with mild vision loss - 20/32 - responded to Avastin19. Dezember 2024
Wet AMD - Occult CNVM and Geographic atrophy75 x angesehen77 year old female with mild vision loss - 20/32 - responded to Avastin19. Dezember 2024
Wet AMD - Occult CNVM and Geographic atrophy90 x angesehen77 year old female with mild vision loss - 20/32 - responded to Avastin19. Dezember 2024
Wet AMD - Occult CNVM and Geographic atrophy90 x angesehen77 year old female with mild vision loss - 20/32 - responded to Avastin19. Dezember 2024
Wet AMD - Occult CNVM and Geographic atrophy108 x angesehen77 year old female with mild vision loss - 20/32 - responded to Avastin19. Dezember 2024
Wet AMD - Occult CNVM and Geographic atrophy102 x angesehen77 year old female with mild vision loss - 20/32 - responded to Avastin19. Dezember 2024
Wet AMD - Occult CNVM and Geographic atrophy92 x angesehen77 year old female with mild vision loss - 20/32 - responded to Avastin19. Dezember 2024
Wet AMD - Occult CNVM and Geographic atrophy83 x angesehen77 year old female with mild vision loss - 20/32 - responded to Avastin19. Dezember 2024
Wet AMD - Occult CNVM and Geographic atrophy93 x angesehen77 year old female with mild vision loss - 20/32 - responded to Avastin19. Dezember 2024
Wet AMD - Occult CNVM and Geographic atrophy114 x angesehen77 year old female with mild vision loss - 20/32 - responded to Avastin19. Dezember 2024
Wet AMD - Occult CNVM and Geographic atrophy68 x angesehen77 year old female with mild vision loss - 20/32 - responded to Avastin19. Dezember 2024
Wet AMD - Occult CNVM and Geographic atrophy100 x angesehen77 year old female with mild vision loss - 20/32 - responded to Avastin19. Dezember 2024
